Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningCombined Modality TherapyTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsAntigens, CD34CyclophosphamideBlood Component RemovalStem Cell TransplantationMultiple MyelomaTreatment OutcomeMyeloablative AgonistsBusulfanLymphoma, Non-HodgkinGraft vs Host DiseaseGraft SurvivalBone Marrow TransplantationEtoposideHematopoietic Stem CellsThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceSalvage TherapyCytophagocytosisCarmustineIfosfamideVincristineAmyloidosisCytarabineStem CellsDisease-Free SurvivalHodgkin DiseaseHematopoiesisCord Blood Stem Cell TransplantationTransplantation ChimeraNeoplasmsSurvival RateRetrospective StudiesTissue DonorsAntineoplastic AgentsWhole-Body IrradiationSurvival AnalysisDoxorubicinTime FactorsInfectionLymphoma, T-CellHistocompatibilityPOEMS SyndromePlatelet CountCarboplatinPrednisoneHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteDexamethasoneTransplantation, IsogeneicVidarabineFollow-Up StudiesBlood Cell CountRecombinant ProteinsLeukemiaBone Marrow PurgingProspective StudiesLymphomaCytomegalovirus InfectionsBlood CellsFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticBlood Transfusion, AutologousLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionPrognosisBreast NeoplasmsT-LymphocytesLeukocytes, MononuclearHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo ReticularisBone MarrowHLA AntigensCyclosporineBlood DonorsImmunosuppressionMesenchymal Stem Cell TransplantationCell Separation